Antibody-Drug Conjugates, Fundamentals, Drug Development, and Clinical Outcomes to Target Cancer, Wiley, John Wiley & Sons,Pharmacology,Medical specialties, branches of medicine, antibody-drug conjugate (ADC); therapeutic oncology; engineered targeted monoclonal antibodies; cancer cell targeting; cytotoxic drugs; oncology drug development; cancer drug development; chemistry manufacturing and controls; nonclinical ADC pharmacology; pharmacokinetics and toxicology; clinical outcomes; oncology clinical trials,, , United States, en-UShttps://www.wiley.comantibody-drug conjugate (ADC); therapeutic oncology; engineered targeted monoclonal antibodies; cancer cell targeting; cytotoxic drugs; oncology drug development; cancer drug development; chemistry manufacturing and controls; nonclinical ADC pharmacology; pharmacokinetics and toxicology; clinical outcomes; oncology clinical trials, [BLURB],[CITY],,books, ebooks, biblet, Book2look